CClinicalTrials.gg
WithdrawnNCT03730467PONCTABCESEINUpdated Apr 3, 2026

Puncture Breast Abscess

An observational study in Breast Abscess, sponsored by Assistance Publique - Hôpitaux de Paris. Withdrawn at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-03.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

Why this study was withdrawn
Study halted prematurely, prior to enrollment of first participant
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
0
Ages
18 Years and older
Sex
Female
01

Study summary

Several breast diseases can complicate breastfeeding : 4% of women develop a mastitis and 1% develop an abscess.

The study deals with cases of breast abscess that have been treated according to a defined protocol (Parisian Perinatal Health Network), by a multidisciplinary team (center of Medical Imaging Duroc) trained in breastfeeding and ultrasound-guided punctures.

The aim of the study is to define the risk factors for the onset of a breast abscess, to evaluate the indications and methods of management of abscess by ultrasound puncture, and to provide arguments motivating the continuation of breastfeeding.

02

Conditions studied

  • Breast Abscess

Browse trials for

Keywords

  • Breast feeding
  • breast abscess
  • ultrasound-guide
  • puncture
  • health
03

In context

Breast Feeding

262 studies on the registry are indexed under Breast Feeding; 112 are open to participants now.

Browse Breast Feeding studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,505 studies on the registry; 1,006 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Women punctured for a breast lactant abscess in the center of Medical Imaging Duroc

Inclusion criteria

  • Nursing mothers
  • Patients referred for breast abscesses during lactation
  • Having an abscess confirmed ultrasoundly and indicating a puncture
  • Women punctured of an abscess of the breast abscess in the center of Medical Imaging Duroc
  • Not opposing the use of them given and to answer the questionnaire on the immediate and medium-term future by telephone
  • Women aged > 18 years old
  • Women understanding French
  • Affiliated to Social Security

Exclusion criteria

Exclusion Criteria:

No

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
0 participants (actual)
Patient registry
No

Interventions

  • BehavioralPhone call to the patient

    Phone call to the patient

06

What researchers measure

Primary outcomes

  1. Continuation of breastfeeding

    Phone call to the patient

    Time frame: 1 week to 6 months after the puncture

Secondary outcomes

  1. Etiology of the abscess

    Medical record and phone call to the patient

    Time frame: 1 week to 6 months after the puncture

  2. Adequacy of medical care with the protocol of the Parisian Perinatal Health Network

    Medical record and phone call to the patient

    Time frame: 1 week to 6 months after the puncture

  3. Relationship between puncture breastfeeding continuation

    Medical record and phone call to the patient

    Time frame: 1 week to 6 months after the puncture

  4. Relationship between surgery and weaning

    Medical record and phone call to the patient

    Time frame: 1 week to 6 months after the puncture

07

Study locations

1 site
  • AP-HP Hopital Necker Enfants malades
    Paris, 75015, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03730467
Lead sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
URC-CIC Paris Descartes Necker Cochin
Responsible party
Sponsor
First posted
Nov 5, 2018
Start date
Sep 4, 2018
Primary completion
Sep 4, 2018
Completion
Sep 4, 2018
Last update
Apr 3, 2026

Study contacts

Virginie Rigourd, MD
principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion